tizanidine 4 MG as tizanidine hydrochloride 4.58 MG Oral Tablet

INDICATIONS AND USAGE Tizanidine tablets are a short-acting drug for the management of spasticity. Because of the short duration of effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important (see DOSAGE AND ADMINISTRATION ).

American Health Packaging

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] pain` `[4] fatigue` `[5] headache` `[6] off label use` `[7] dyspnoea` `[8] arthralgia` `[9] pneumonia` `[10] diarrhoea`

11 months ago

OVAL WHITE R180

11 months ago

R180 OVAL WHITE

HOW SUPPLIED Tizanidine hydrochloride Tablets 4 mg are white to off white, oval, flat, beveled edged tablets embossed with “R180” on one side and “quadrisecting score” on other side. The tablets are available in: Unit dose packages of 100 (10x10) NDC 68084-013-01 Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Rx Only PACKAGING INFORMATION American Health Packaging unit dose blisters (see How Supplied section) contain drug product from Dr. Reddy’s Laboratories Limited as follows: (4 mg / 100 UD) NDC 68084-013-01 packaged from NDC 55111-180 Packaged and Distributed by: American Health Packaging Columbus, OH 43217 8201301/0712

More pills like OVAL R180

Related Pills

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site